Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study
- PMID: 25894629
- DOI: 10.1007/s00380-015-0678-9
Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study
Abstract
The cholesterol-esterifying enzyme, lecithin-cholesterol acyltransferase (LCAT), is believed to play a key role in reverse cholesterol transport. However, recent investigations have demonstrated that higher LCAT activity levels increase the formation of triglyceride (TG)-rich lipoproteins (TRLs) and atherogenesis. We hypothesized that higher LCAT activity measured as a serum cholesterol esterification rate by the endogenous substrate method might increase the formation of TRLs and thereby alter low-density lipoprotein (LDL) heterogeneity. The estimated LDL particle size [relative LDL migration (LDL-Rm)] was measured by polyacrylamide gel electrophoresis with the LipoPhor system (Joko, Tokyo, Japan) in 538 consecutive patients with at least risk factor for atherosclerosis. Multivariate regression analysis after adjustments for traditional risk factors identified elevated TRL-related marker (TG, remnant-like particle cholesterol, apolipoprotein C-II, and apolipoprotein C-III) levels as independent predictors of smaller-sized LDL particle size, both in the overall subject population and in the subset of patients with serum LDL cholesterol levels of <100 mg/dL. Area under the receiver operating characteristic curve of the LCAT activity (0.79; sensitivity 60 %; specificity 84.8 %) was observed for the evaluation of the indicators of an LDL-Rm value of ≥0.40, which suggests the presence of large amounts of small-dense LDL. The results lend support to the hypothesis that increased LCAT activity may be associated with increased formation of TRLs, leading to a reduction in LDL particle size. Therefore, to reduce the risk of atherosclerotic cardiovascular disease, it may be of importance to pay attention not only to a quantitative change in the serum LDL-C, but also to the LCAT activity which is possibly associated with LDL heterogeneity.
Keywords: Atherosclerosis; LDL particle size; Lecithin–cholesterol acyltransferase; Triglyceride-rich lipoproteins.
Similar articles
-
Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study.BMC Cardiovasc Disord. 2018 Dec 5;18(1):224. doi: 10.1186/s12872-018-0967-1. BMC Cardiovasc Disord. 2018. PMID: 30518338 Free PMC article.
-
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.J Cardiol. 2014 Jan;63(1):60-8. doi: 10.1016/j.jjcc.2013.06.018. Epub 2013 Sep 7. J Cardiol. 2014. PMID: 24016623
-
Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study.Coron Artery Dis. 2017 Nov;28(7):577-587. doi: 10.1097/MCA.0000000000000521. Coron Artery Dis. 2017. PMID: 28692480
-
The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.Biochim Biophys Acta. 2012 Apr;1821(4):654-9. doi: 10.1016/j.bbalip.2011.12.012. Epub 2012 Jan 12. Biochim Biophys Acta. 2012. PMID: 22326749 Review.
-
[LCAT (lecithin:cholesterol acyltransferase)].Rinsho Byori. 2001 Nov;Suppl 116:125-30. Rinsho Byori. 2001. PMID: 11797372 Review. Japanese.
Cited by
-
Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.Heart Vessels. 2019 Feb;34(2):227-236. doi: 10.1007/s00380-018-1247-9. Epub 2018 Aug 23. Heart Vessels. 2019. PMID: 30140959
-
Lecithin and cardiovascular health: a comprehensive review.Egypt Heart J. 2024 Jul 13;76(1):92. doi: 10.1186/s43044-024-00523-0. Egypt Heart J. 2024. PMID: 39001966 Free PMC article. Review.
-
Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis.Metabolites. 2021 Jul 16;11(7):459. doi: 10.3390/metabo11070459. Metabolites. 2021. PMID: 34357353 Free PMC article.
-
A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity.Heart Vessels. 2018 May;33(5):470-480. doi: 10.1007/s00380-017-1082-4. Epub 2017 Nov 20. Heart Vessels. 2018. PMID: 29159568 Free PMC article.
-
Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study.BMC Cardiovasc Disord. 2018 Dec 5;18(1):224. doi: 10.1186/s12872-018-0967-1. BMC Cardiovasc Disord. 2018. PMID: 30518338 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous